Publisher
Springer Berlin Heidelberg
Reference42 articles.
1. Abbott FM, Reichman JH (2007) The Doha Round’s public health legacy: strategies for the production and diffusion of patented medicines under the amended TRIPS provisions. J Int Econ Law 10:921–987
2. Aziz S (2003) Linking intellectual property rights in developing countries with research and development, technology transfer, and foreign direct investment policy: a case study of Egypt’s pharmaceutical industry. ILSA J Int Comp Law 10(1)
3. Balasubramaniam K (2002) Access to medicines: patents, prices and public policy – consumer perspectives. In: Drahos P, Mayne R (eds) Global intellectual property rights: knowledge, access and development. Palgrave MacMillan, Hampshire
4. Banta D (2001) Public health triumphs at WTO conference. J Am Med Assoc 286:2655–2656
5. Beall R, Kuhn R (2012) Trends in compulsory licensing of pharmaceuticals since the Doha Declaration: a database analysis. PLoS Med 9(1):e1001154. doi:
10.1371/journal.pmed.1001154
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献